Latest News & Features
Big Pharma
Patient choice is at the heart of plans in the UK to expedite access to pharma-branded medicines in the NHS, but how will innovator companies be affected? LSIPR reports. 11 February 2016
Americas
Following several high-profile decisions by the US Supreme Court making it harder to patent biotech inventions, parties should follow several best practices to give their products the best chance of being patented. Kathryn Hull of Gordon Rees provides some tips. 11 February 2016
Americas
An advisory committee at the US Food and Drug Administration has said that pharmaceutical company Celltrion’s proposed biosimilar used to treat Crohn’s disease and rheumatoid arthritis should be approved for sale. 10 February 2016
Americas
A biotechnology company that licenses a patent related to the gene-editing technology CRISPR/Cas9 has raised more than $94 million in its initial share offering. 10 February 2016
Asia
India’s weak intellectual property enforcement regime and its vague grounds centring on compulsory licences for drugs are reasons it should remain on the “Priority Watch List” in this year’s "Special 301 Report", a pharmaceutical industry association has argued. 9 February 2016
Big Pharma
Law firm Carpmaels & Ransford has hired David Wilson and Jake Marshall as partners in the firm’s patent litigation and life sciences practices. 9 February 2016
Americas
Supernus Pharmaceuticals has defeated Actavis in a patent infringement dispute centring on epilepsy drug Oxtellar XR. 8 February 2016
Americas
The US Court of Appeals for the Federal Circuit has revived medical device company TriReme Medical’s attempt to correct the record of three patents related to catheters. 8 February 2016
Americas
A man who sold and imported counterfeit drugs, including Viagra and Diazepam, into the US has appeared in court. 8 February 2016
Americas
The chief executive of biotechnology Twist Bioscience has been accused of stealing trade secrets belonging to her former employer. 5 February 2016